- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 380193, 8 pages
Significance of Glutathione Peroxidase 1 and Caudal-Related Homeodomain Transcription Factor in Human Gastric Adenocarcinoma
1Department of Pathology, Zengcheng People’s Hospital, Zengcheng City 511300, China
2Department of Pathology, Sun Yat-Sen Memorial Hospital, Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-Sen University, Guangzhou 510120, China
3Department of Oncology, Sun Yat-Sen Memorial Hospital, Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-Sen University, Guangzhou 510120, China
4Department of Oral and Maxillofacial Surgery, Sun Yat-Sen Memorial Hospital, Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-Sen University, Guangzhou 510120, China
Received 1 August 2013; Accepted 2 September 2013
Academic Editor: Chunping Jiang
Copyright © 2013 Jing Jing Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Lambert, A. Guilloux, A. Oshima et al., “Incidence and mortality from stomach cancer in Japan, Slovenia and the USA,” International Journal of Cancer, vol. 97, no. 6, pp. 811–818, 2002.
- J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, et al., “Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012,” European Journal of Cancer, vol. 49, no. 6, pp. 1374–1403, 2013.
- W. Chen, R. Zheng, S. Zhang, et al., “Report of incidence and mortality in China cancer registries, 2009,” Chinese Journal of Cancer Research, vol. 25, no. 1, pp. 10–21, 2013.
- J. R. Siewert, K. Böttcher, H. J. Stein, and J. D. Roder, “Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study,” Annals of Surgery, vol. 228, no. 4, pp. 449–461, 1998.
- K. Laimer, D. Fong, G. Gastl et al., “EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features,” Oral Oncology, vol. 44, no. 1, pp. 72–77, 2008.
- B. Halliwell, “Antioxidant defence mechanisms: from the beginning to the end (of the beginning),” Free Radical Research, vol. 31, no. 4, pp. 261–272, 1999.
- Y. Miyamoto, Y. H. Koh, Y. S. Park et al., “Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses,” Biological Chemistry, vol. 384, no. 4, pp. 567–574, 2003.
- G. Ray and S. A. Husain, “Oxidants, antioxidants and carcinogenesis,” Indian Journal of Experimental Biology, vol. 40, no. 11, pp. 1213–1232, 2002.
- R. Brigelius-Flohé and A. Kipp, “Glutathione peroxidases in different stages of carcinogenesis,” Biochimica et Biophysica Acta, vol. 1790, no. 11, pp. 1555–1568, 2009.
- S. Y. Min, H. S. Kim, E. J. Jung, et al., “Prognostic significance of glutathione peroxidase 1 (GPX1) down-regulation and correlation with aberrant promoter methylation in human gastric cancer,” Anticancer Research, vol. 32, no. 8, pp. 3169–3175, 2012.
- I. Gross, I. Duluc, T. Benameur et al., “The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells,” Oncogene, vol. 27, no. 1, pp. 107–115, 2008.
- C. Bonhomme, I. Duluc, E. Martin et al., “The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development,” Gut, vol. 52, no. 10, pp. 1465–1471, 2003.
- A. Eda, H. Osawa, K. Satoh et al., “Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa,” Journal of Gastroenterology, vol. 38, no. 1, pp. 14–22, 2003.
- R. Almeida, E. Silva, F. Santos-Silva et al., “Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas,” Journal of Pathology, vol. 199, no. 1, pp. 36–40, 2003.
- R. Barros, V. Camilo, B. Pereira, J.-N. Freund, L. David, and R. Almeida, “Pathophysiology of intestinal metaplasia of the stomach: emphasis on CDX2 regulation,” Biochemical Society Transactions, vol. 38, no. 2, pp. 358–363, 2010.
- D. F. Peng, M. Razvi, H. Chen et al., “DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma,” Gut, vol. 58, no. 1, pp. 5–15, 2009.
- T. Mizoshita, T. Tsukamoto, H. Nakanishi et al., “Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis,” Journal of Cancer Research and Clinical Oncology, vol. 129, no. 12, pp. 727–734, 2003.
- L. Gan, Q. Liu, H.-B. Xu, Y.-S. Zhu, and X.-L. Yang, “Effects of selenium overexposure on glutathione peroxidase and thioredoxin reductase gene expressions and activities,” Biological Trace Element Research, vol. 89, no. 2, pp. 165–175, 2002.
- A. Martinez, R. A. Walker, J. A. Shaw, S. J. Dearing, E. R. Maher, and F. Latif, “Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features,” Journal of Clinical Pathology, vol. 54, no. 5, pp. 300–306, 2001.
- Y. J. Hu and A. M. Diamond, “Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium,” Cancer Research, vol. 63, no. 12, pp. 3347–3351, 2003.
- C. Huang, G. Ding, C. Gu, et al., “Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1 to promote hepatocellular carcinoma invasiveness,” Clinical Cancer Research, vol. 18, no. 11, pp. 3042–3053, 2012.
- Y. Hu, S. Rahlfs, V. Mersch-Sundermann, and K. Becker, “Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells,” Biological Chemistry, vol. 388, no. 2, pp. 207–219, 2007.
- T. Mizoshita, K.-I. Inada, T. Tsukamoto et al., “Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa—with special emphasis on participation in intestinal metaplasia of the human stomach,” Gastric Cancer, vol. 4, no. 4, pp. 185–191, 2001.
- H. Seno, M. Oshima, M.-A. Taniguchi et al., “CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: prognostic implications,” International Journal of Oncology, vol. 21, no. 4, pp. 769–774, 2002.
- P. Correa, “Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society Award lecture on cancer epidemiology and prevention,” Cancer Research, vol. 52, no. 24, pp. 6735–6740, 1992.
- B. H. Lee, N. Kim, H. S. Lee et al., “The role of CDX2 in intestinal metaplasia evaluated using immunohistochemistry,” Gut and Liver, vol. 6, no. 1, pp. 71–77, 2012.
- X. T. Wang, W. Y. Wei, F. B. Kong, et al., “Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures,” Journal of Experimental & Clinical Cancer Research, vol. 31, no. 1, p. 98, 2012.
- S. Hayes, S. Ahmed, and P. Clark, “Immunohistochemical assessment for Cdx2 expression in the Barrett metaplasia-dysplasia-adenocarcinoma sequence,” Journal of Clinical Pathology, vol. 64, no. 2, pp. 110–113, 2011.
- D. Y. Park, A. Srivastava, G. H. Kim et al., “CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance,” Modern Pathology, vol. 23, no. 1, pp. 54–61, 2010.
- W.-P. Lee, C.-L. Lee, and H.-C. Lin, “Glutathione S-transferase and glutathione peroxidase are essential in the early stage of Adriamycin resistance before P-glycoprotein overexpression in HOB1 lymphoma cells,” Cancer Chemotherapy and Pharmacology, vol. 38, no. 1, pp. 45–51, 1996.
- Y. Takakura, T. Hinoi, N. Oue et al., “CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium,” Cancer Research, vol. 70, no. 17, pp. 6767–6778, 2010.